Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Grupp, SA; Laetsch, TW; Buechner, J; Bittencourt, H; Maude, SL; Verneris, MR; Myers, GD; Boyer, MW; Rives, S; De Moerloose, B; Nemecek, ER; Schlis, K; Martin, PL; Qayed, M; Bader, P; Hiramatsu, H; Mechinaud, F; Yanik, GA; Peters, C; Biondi, A; Baruchel, A; Boissel, N; Krueger, J; June, CH; Sen, K; Zhang, Y; Thudium, KE; Wood, PA; Taran, T; Pulsipher, MA

Published Date

  • December 2, 2016

Published In

Volume / Issue

  • 128 / 22

Published By


  • 7

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 3, 2016

Conference End Date

  • December 6, 2016